Francis G S, Goldsmith S R, Cohn J N
Am Heart J. 1982 Oct;104(4 Pt 1):725-31. doi: 10.1016/0002-8703(82)90003-5.
Seventeen patients with chronic congestive heart failure (CHF) were studied to assess the relationship of resting left ventricular function, as measured by noninvasive and invasive methods, to maximal exercise capacity, as measured by peak total body oxygen consumption (VO2). Supine basal plasma norepinephrine (NE) was also measured to evaluate its relationship to the severity of heart failure and to determine whether it may be a better predictor of exercise capacity in patients with CHF than the more commonly employed noninvasive and invasive tests of left ventricular function. Fourteen of the 17 patients underwent upright bicycle exercise (average peak VO2 10.60 +/- 1.40 ml/kg/min, +/- SEM) to their symptomatic maximum. There was no significant correlation between peak VO2 and the noninvasive measurements of left ventricular performance obtained at rest, including cardiothoracic ratio, left ventricular internal dimension by M-mode echo, percent shortening of the minor axis by M-mode echo, and radionuclide ejection fraction. Hemodynamic measurements were performed in 16 patients. The hemodynamic measurements at rest also failed to correlate with exercise capacity. The supine basal plasma NE, which was elevated in these 17 patients (612 +/- 100 pg/ml), had an inverse relationship with stroke work index (r - -0.70, p less than 0.01) and stroke index (r = -0.83, p less than 0.001) and a positive correlation with right atrial pressure (r = 0.81, p less than 0.001). Although both noninvasive and invasive measurements at rest failed to correlate significantly with peak VO2 during exercise, the plasma NE had a significant inverse correlation with peak exercise VO2 (r = -0.50, p less than 0.05). The basal supine plasma NE is therefore elevated in patients with CHF, is a marker for the severity of CHF as measured by hemodynamics performed at rest, and is a better predictor of exercise capacity than standard noninvasive and invasive tests performed at rest.
对17例慢性充血性心力衰竭(CHF)患者进行了研究,以评估通过非侵入性和侵入性方法测得的静息左心室功能与通过峰值全身耗氧量(VO2)测得的最大运动能力之间的关系。还测量了仰卧位基础血浆去甲肾上腺素(NE),以评估其与心力衰竭严重程度的关系,并确定它是否比更常用的左心室功能非侵入性和侵入性测试更能预测CHF患者的运动能力。17例患者中有14例进行了直立自行车运动,直至出现症状的最大值(平均峰值VO2为10.60±1.40 ml/kg/min,±标准误)。峰值VO2与静息时获得的左心室功能的非侵入性测量值之间无显著相关性,这些测量值包括心胸比率、M型超声心动图测得的左心室内径、M型超声心动图测得的短轴缩短百分比以及放射性核素射血分数。对16例患者进行了血流动力学测量。静息时的血流动力学测量值也与运动能力无关。这17例患者的仰卧位基础血浆NE升高(612±100 pg/ml),与每搏功指数呈负相关(r = -0.70,p<0.01),与每搏指数呈负相关(r = -0.83,p<0.001),与右心房压力呈正相关(r = 0.81,p<0.001)。虽然静息时的非侵入性和侵入性测量值与运动时的峰值VO2均无显著相关性,但血浆NE与运动峰值VO2呈显著负相关(r = -0.50,p<0.05)。因此,CHF患者的仰卧位基础血浆NE升高,是静息时通过血流动力学测量的CHF严重程度的标志物,并且比静息时进行标准的非侵入性和侵入性测试更能预测运动能力。